论文部分内容阅读
Background Damage to the vascular endothelium may be one of the pathophysiological causes of in-stent thrombosis and restenosis.Endothelial progenitor cell (EPC) capture stents (ECS) have the ability to accelerate the damage repair process.However,the clinical outcomes of ECS remain unknown thus far.